OTC Fast Facts
- Hispanics are driving the growth in headache/pain remedies.
Hispanics accounted for 1 out of every 3 new headache/pain remedy users from 2006 – 2010.
Source: Simmons NCS/NHCS: Fall 2006 – 2010 Adult Full Year – Pop, Base: A18+
- Hispanics are more likely to use children’s OTC remedies.
Thirty-five percent of Hispanics use children’s fever/pain relievers vs. 23% of Non-Hispanics; and 29% of Hispanics use children’s cough/cold products vs. 17% of Non-Hispanics.
Source: Simmons NCS/NHCS: Fall 2010 Adult Full Year – Pop, Base: A18+
- The importance of familia extends to health concerns.
Sixty-two percent of Hispanics “worry about the health of other family members” vs. 47% of Non-Hispanic Whites. The concern also covers the idea of providing care as 42% of Hispanics vs. 23% of Non-Hispanic Whites are worried about “taking care of elderly family members”.
Source: Yankelovich MONITOR Multicultural Study 2010, Base: Persons 16+
- Hispanics are less likely to use private label OTC remedies.
Private label captures 27% of Hispanic cold/allergy/sinus remedy sales vs. 33% of Non-Hispanic sales. For internal analgesics, private label accounts for 33% of Hispanic sales vs. 38% of Non-Hispanic sales.
Source: IRI Ethnic Workbench Scan Data – 52 Weeks Ending 6/26/201, Cold/Allergy/Sinus Liquids/Tablets and Internal Analgesics categories.
- Hispanic OTC sales offer over 1 billion dollars in incremental growth opportunity.
Hispanics currently contribute $2.1 Billion or 11% of total U.S. OTC sales. Reaching census parity would see this number grow to $3.5 Billion.
Source: IRI Ethnic Workbench Scan Data – 52 Weeks Ending 6/26/201 based on 19 OTC categories.